GPR88 localization to primary cilia and its impact on striatal cAMP signaling

NIH RePORTER · NIH · R01 · $393,050 · view on reporter.nih.gov ↗

Abstract

PROJECT SUMMARY / ABSTRACT This proposal seeks to elucidate the basic cellular neurobiology of GPR88, an orphan G protein-coupled receptor (GPCR) that is of great interest as a potential therapeutic target for neuropsychiatric disease but remains poorly understood at the level of cellular mechanism. The project begins (Specific Aim 1) with a detailed anatomical and morphological characterization of GPR88 expression in brain and across development, building on preliminary studies indicating that GPR88 is developmentally regulated and is differentially targeted to or excluded from primary cilia in distinct neuronal populations. It then focuses on delineating the mechanistic basis of selective targeting of GPR88 to neuronal cilia (Specific Aim 2), and determining how GPR88 modulates signaling in relevant striatal neurons and how ciliary receptor localization or exclusion changes this function (Specific Aim 3). The proposed studies build on recent advances in GPR88 pharmacology and signaling biosensor tool development. These studies seek to provide the first direct evidence regarding the effects of GPR88 on neuromodulation at native receptor expression levels, define functional consequences of GPR88 localization to primary cilia of neurons, and help delineate a framework for understanding the functional consequence(s) of primary cilia in GPCR-mediated neuromodulation more generally.

Key facts

NIH application ID
9996796
Project number
5R01MH120212-02
Recipient
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
Principal Investigator
Mark E VonZastrow
Activity code
R01
Funding institute
NIH
Fiscal year
2020
Award amount
$393,050
Award type
5
Project period
2019-08-15 → 2024-05-31